Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 11.

Journal Article

Breyer, Johannes, Otto, Wolfgang, Wirtz, Ralph M., Wullich, Bernd, Keck, Bastian, Erben, Philipp ORCID: 0000-0002-8279-7636, Kriegmair, Maximilian C., Stoehr, Robert, Eckstein, Markus, Laible, Mark, Schlombs, Kornelia, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2017). ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urol.Int., 98 (3). S. 282 - 290. BASEL: KARGER. ISSN 1423-0399

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp ORCID: 0000-0002-8279-7636, Rinaldetti, Sebastien, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2019). FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU Int., 123 (1). S. 187 - 197. HOBOKEN: WILEY. ISSN 1464-410X

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp ORCID: 0000-0002-8279-7636, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018). High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clin. Genitourin. Cancer, 16 (4). S. 248 - 259. DALLAS: CIG MEDIA GROUP, LP. ISSN 1938-0682

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp ORCID: 0000-0002-8279-7636, Kriegmair, Maximilian C., Stoehr, Robert, Eckstein, Markus, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2017). In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Arch., 470 (3). S. 267 - 275. NEW YORK: SPRINGER. ISSN 1432-2307

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp ORCID: 0000-0002-8279-7636, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2018). High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients. Cancer Immunol. Immunother., 67 (3). S. 403 - 413. NEW YORK: SPRINGER. ISSN 1432-0851

Eckstein, Markus, Wirtz, Ralph Markus, Gross-Weege, Matthias, Breyer, Johannes, Otto, Wolfgang, Stoehr, Robert, Sikic, Danijel, Keck, Bastian, Eidt, Sebastian, Burger, Maximilian, Bolenz, Christian, Nitschke, Katja, Porubsky, Stefan ORCID: 0000-0002-7647-7265, Hartmann, Arndt and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants. Int. J. Mol. Sci., 19 (11). BASEL: MDPI. ISSN 1422-0067

Juette, Hendrik, Reike, Moritz, Wirtz, Ralph M., Kriegmair, Maximilian, Erben, Philipp, Tully, Karl, Weyerer, Veronika, Eckstein, Markus, Hartmann, Arndt, Eidt, Sebastian ORCID: 0000-0003-0891-1936, Wezel, Felix, Bolenz, Christian, Tannapfel, Andrea, Noldus, Joachim and Roghmann, Florian (2021). KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. J. Pers. Med., 11 (6). BASEL: MDPI. ISSN 2075-4426

Kluemper, Niklas, Ralser, Damian J., Zarbl, Romina, Schlack, Katrin, Schrader, Andres Jan, Rehlinghaus, Marc, Hoffmann, Michele J., Niegisch, Guenter, Uhlig, Annemarie, Trojan, Lutz, Steinestel, Julie, Steinestel, Konrad, Wirtz, Ralph M., Sikic, Danijel, Eckstein, Markus, Kristiansen, Glen, Toma, Marieta, Hoelzel, Michael, Ritter, Manuel, Strieth, Sebastian, Ellinger, Joerg and Dietrich, Dimo (2021). CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma. J. Immunother. Cancer, 9 (8). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Leone, Marina ORCID: 0000-0001-6839-6265, Cazorla-Vazquez, Salvador, Ferrazzi, Fulvia ORCID: 0000-0003-4011-4638, Wiederstein, Janica L., Gruendl, Marco, Weinstock, Grit, Vergarajauregui, Silvia ORCID: 0000-0002-9247-6123, Eckstein, Markus, Krueger, Marcus, Gaubatz, Stefan ORCID: 0000-0001-8751-4191 and Engel, Felix B. ORCID: 0000-0003-2605-3429 (2021). IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability. Mol. Cancer Res., 19 (10). S. 1712 - 1727. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3125

Martini, Thomas, Heinkele, Jakob, Mayr, Roman, Weis, Cleo-Aron, Wezel, Felix, Wahby, Sarah, Eckstein, Markus, Schnoller, Thomas, Breyer, Johannes, Wirtz, Ralph, Ritter, Manuel, Bolenz, Christian and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy. Urol. Oncol.-Semin. Orig. Investig., 36 (12). NEW YORK: ELSEVIER SCIENCE INC. ISSN 1873-2496

Worst, Thomas S., Weis, Cleo-Aron, Stoehr, Robert, Bertz, Simone, Eckstein, Markus, Otto, Wolfgang, Breyer, Johannes, Hartmann, Arndt, Bolenz, Christian, Wirtz, Ralph M. and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Sci Rep, 8. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

This list was generated on Thu May 19 03:03:53 2022 CEST.